Company Filing History:
2 out of 173 
2 out of 7 
1 out of 22 
Years Active: 2020-2024
Title: The Innovations of Inventor Matthew McGee
Introduction
Matthew McGee, a dedicated inventor based in Vacaville, CA, has contributed significantly to the field of biotechnology with his innovative research and development. With two patents to his name, he has focused primarily on advancements related to endostatin, a protein known for its potential in treating various medical conditions, particularly fibrosis.
Latest Patents
Matthew's latest patents include groundbreaking work on endostatin fragments and variants for use in treating fibrosis. The first patent details materials and methods for utilizing polypeptides containing fragments and variants of endostatin aimed at fibrosis treatment. His second patent outlines methods for producing endostatin fusion polypeptides in plant cells that exhibit anti-fibrotic activity. These fusion polypeptides combine an IgG Fc domain with a portion of human endostatin, allowing the formation of high molecular weight multimers, enhancing therapeutic effectiveness.
Career Highlights
Throughout his career, Matthew McGee has collaborated with various organizations, lending his expertise to propel forward the field of medical research. Notably, he has worked with the Musc Foundation for Research Development and Novici Biotech LLC, where his contributions have helped to advance critical understanding and applications of biotechnological innovations.
Collaborations
Matthew has also collaborated with esteemed professionals in his field, including Carol A. Feghali-Bostwick and Terence E. Ryan. These partnerships underscore the collaborative nature of scientific research and highlight the importance of teamwork in driving innovation for healthcare advancements.
Conclusion
As an inventor, Matthew McGee exemplifies the spirit of innovation within the biotechnology arena. His patents on endostatin-related treatments not only demonstrate his commitment to medical progress but also represent a significant contribution to the ongoing fight against fibrosis. Through his work and collaborations, he continues to inspire future developments in the field, paving the way for new therapeutic approaches.